Last reviewed · How we verify
Xiaoer Jiebiao Oral Liquid
Xiaoer Jiebiao Oral Liquid is a Small molecule drug developed by Guangzhou Yipinhong Pharmaceutical CO.,LTD. It is currently FDA-approved for Pediatric fever associated with common cold and upper respiratory infections, Fever management in children. Also known as: No other names.
Xiaoer Jiebiao Oral Liquid is a traditional Chinese medicine formulation that promotes fever resolution and supports immune function in pediatric patients.
Xiaoer Jiebiao Oral Liquid is a traditional Chinese medicine formulation that promotes fever resolution and supports immune function in pediatric patients. Used for Pediatric fever associated with common cold and upper respiratory infections, Fever management in children.
At a glance
| Generic name | Xiaoer Jiebiao Oral Liquid |
|---|---|
| Also known as | No other names |
| Sponsor | Guangzhou Yipinhong Pharmaceutical CO.,LTD |
| Modality | Small molecule |
| Therapeutic area | Pediatrics / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
This herbal oral liquid is designed to help the body resolve febrile illnesses by promoting sweating and heat dissipation while supporting natural immune responses. The formulation combines multiple botanical ingredients traditionally used in Chinese medicine to address fever and related symptoms in children. It works through systemic effects rather than targeting a single molecular pathway.
Approved indications
- Pediatric fever associated with common cold and upper respiratory infections
- Fever management in children
Common side effects
Key clinical trials
- Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease (PHASE4)
- The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Xiaoer Jiebiao Oral Liquid CI brief — competitive landscape report
- Xiaoer Jiebiao Oral Liquid updates RSS · CI watch RSS
- Guangzhou Yipinhong Pharmaceutical CO.,LTD portfolio CI
Frequently asked questions about Xiaoer Jiebiao Oral Liquid
What is Xiaoer Jiebiao Oral Liquid?
How does Xiaoer Jiebiao Oral Liquid work?
What is Xiaoer Jiebiao Oral Liquid used for?
Who makes Xiaoer Jiebiao Oral Liquid?
Is Xiaoer Jiebiao Oral Liquid also known as anything else?
What development phase is Xiaoer Jiebiao Oral Liquid in?
Related
- Manufacturer: Guangzhou Yipinhong Pharmaceutical CO.,LTD — full pipeline
- Therapeutic area: All drugs in Pediatrics / Infectious Disease
- Indication: Drugs for Pediatric fever associated with common cold and upper respiratory infections
- Indication: Drugs for Fever management in children
- Also known as: No other names
- Compare: Xiaoer Jiebiao Oral Liquid vs similar drugs
- Pricing: Xiaoer Jiebiao Oral Liquid cost, discount & access